Actionable news
All posts from Actionable news
Actionable news in ACAD: ACADIA Pharmaceuticals Inc.,

What To Do With Your Relypsa Winnings


Based on biotech analyst Julia Skripka-Serry's prediction of a Relypsa buyout, we suggested a course correction to hedged Relypsa longs at the end of April.

We recap how that course correction affected hedged Relypsa long's exit price.

We also share Skripka-Serry's suggestion about what to look for in potential buyout candidates, and a couple of names she has in mind now.

Roller Coaster Ride Ends On A High

After shares of Relypsa (NASDAQ:RLYP), maker of the hyperkalemia treatment...